Plus Therapeutics, Inc. (PSTV)
5.90
-0.24
(-3.91%)
USD |
NASDAQ |
May 01, 09:58
Plus Therapeutics EPS Diluted (Quarterly) : -1.03 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Boston Scientific Corp. | 0.897 |
| Apyx Medical Corp. | -0.0308 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.713M |
| Revenue (Quarterly) | 1.367M |
| Total Expenses (Quarterly) | 7.08M |
| Enterprise Value | 29.84M |
| Gross Profit Margin (Quarterly) | 93.27% |
| Profit Margin (Quarterly) | -417.9% |
| Earnings Yield | -543.8% |
| Normalized Earnings Yield | -366.90 |